NCT04192123View on ClinicalTrials.gov

Open-Label Test of the HM242 Medical Devices to Evaluate Safety and Local Tolerability

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 25, 2020

Primary Completion Date

June 19, 2020

Study Completion Date

June 19, 2020

Conditions
Intact Skin
Interventions
DEVICE

HM242

HM242-Solution and HM242-Gel will be topically applied in an occlusive patch for 48h on healthy skin on the subject's outer part of the upper arm.

Trial Locations (1)

22609

Dermatologische Praxis Prager & Partner, Hamburg

All Listed Sponsors
lead

B. Braun Ltd. Centre of Excellence Infection Control

INDUSTRY

NCT04192123 - Open-Label Test of the HM242 Medical Devices to Evaluate Safety and Local Tolerability | Biotech Hunter | Biotech Hunter